Farum, Denmark

Jakob Oest Wielandt

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Copenhagen, DK (2016 - 2022)
  • Farum, DK (2022)

Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jakob Oest Wielandt: Innovator in Drug Delivery Technology

Introduction

Jakob Oest Wielandt is a notable inventor based in Farum, Denmark. He has made significant contributions to the field of drug delivery devices, holding a total of 4 patents. His work focuses on enhancing the efficiency and accuracy of insulin delivery systems.

Latest Patents

Wielandt's latest patents include a "Rotary dosage sensing module for and in a disposable pen drug delivery device." This invention features a dosage sensing module that comprises a power source unit, a processor unit, and a dosage sensor unit. The first sensor part is designed to be fixed to a non-rotating part during dose expelling, utilizing a flexible printed circuit board with a pattern of conductive sensor areas. The second sensor part is attached to the piston rod, allowing it to follow the rotation during dose expelling. This innovative design enables the generation of electrical signals indicative of the relative rotational position between the two sensor parts.

Another significant patent is the "Starter kit for basal insulin titration." This system provides methods for treating subjects by obtaining timestamped autonomous glucose measurements and insulin regimen data. The collected datasets are used to calculate a glycaemic risk measure and an insulin sensitivity factor, which help in creating a basal titration schedule and a fasting blood glucose profile model. This model predicts the fasting blood glucose level based on the amounts of basal insulin injected.

Career Highlights

Jakob Oest Wielandt is currently employed at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. His work at Novo Nordisk has allowed him to focus on developing innovative solutions for insulin delivery, significantly impacting patient care.

Collaborations

Wielandt collaborates with esteemed colleagues such as Torben Stroem Hansen and Lars Moerch Groth. Their combined expertise contributes to the advancement of drug delivery technologies.

Conclusion

Jakob Oest Wielandt is a prominent figure in the field of drug delivery innovation, with a focus on improving insulin delivery systems. His patents reflect a commitment to enhancing patient outcomes through technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…